← Open Payments lookup

MICHAEL ASBACH: Open Payments

NPI 1699030411 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$296,343 in 674 payments from 25 companies in 2025. Trend: 2023 $194,833 · 2024 $225,855 · 2025 $296,343

Speaker / faculty: $146,710Honoraria: $66,238Consulting: $46,896Travel & lodging: $24,255Food & beverage: $12,189Education: $55
CompanyPaymentsAmount
Axsome Therapeutics, Inc.114$71,766
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)117$61,084
Janssen Pharmaceuticals, Inc94$56,718
E.R. Squibb & Sons, L.L.C.80$56,339
Neurocrine BioSciences, Inc.67$26,186
Teva Pharmaceuticals USA, Inc.45$13,536
Otsuka America Pharmaceutical, Inc.51$7,797
Janssen Scientific Affairs, LLC11$1,528
Alkermes, Inc.18$289
Lundbeck LLC21$277

Products named: Auvelity, CAPLYTA, SPRAVATO, INGREZZA, COBENFY, UZEDY, REXULTI, ARISTADA.

Industry payments across NY — which companies pay providers there.